Rapid susceptibility methods showed no clear difference in mortality compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (subgroup genotypic) compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (subgroup phenotypic) compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (with stewardship) compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (without stewardship) compared with standard methods versus placebo (low certainty).
It is very uncertain whether rapid antiretroviral therapy (ART) changes mortality at 12 months compared with standard care (very low certainty).
Rapid antiretroviral therapy (ART) probably leads to higher virological suppression at 12 months compared with standard care (moderate certainty).
Rapid antiretroviral therapy (ART) may leads to higher retention in care at 12 months compared with standard care (low certainty).
Rapid antiretroviral therapy (ART) may leads to higher uptake of ART at 90 days compared with standard care (low certainty).
Rapid antiretroviral therapy (ART) probably leads to higher uptake of ART at 12 months compared with standard care (moderate certainty).
It is very uncertain whether rapid antiretroviral therapy (ART) changes treatment modification compared with standard care (very low certainty).
Malaria rapid diagnostic test (mRDT) probably leads to lower antimalarial prescribing to microscopy‐ or PCR‐negative people compared with clinical diagnosis (moderate certainty).
Malaria rapid diagnostic test (mRDT) leads to higher composite appropriate treatment compared with clinical diagnosis (high certainty).
Malaria rapid diagnostic test (mRDT) may leads to lower number of people receiving an antimalarial compared with clinical diagnosis (low certainty).
Malaria rapid diagnostic test (mRDT) probably leads to higher antibiotic prescribing to microscopy‐ or PCR‐negative people compared with clinical diagnosis (moderate certainty).